Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2022 · 10-Q
Revenue$32.99M$32.99M+1.3% vs Q2 2021 Net Income$1.82M$1.82M−75.7% vs Q2 2021 EPS Diluted$0.00$0.00−100.0% vs Q2 2021 Gross Profit$15,005,000−22.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,261,000N/M Free Cash Flowderived-$10,100,000N/M Margins · derivedGross margin45.5%−14.1 pt vs Q2 2021
Operating margin13.6%−23.2 pt vs Q2 2021
Net margin5.5%−17.5 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 9, 2022 · 40 d after period end